Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefotaxime Resistance in SBP Treatment
NCT02388035Phase 4Completed
- Start
- Mar 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefotaxime in spontaneous bacterial peritonitis (SBP). Started Mar 2015; status: completed.
02
Drugs
cefotaxime
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT02388035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02388035.